Literature DB >> 3134265

Nonenzymatic glycation of basement membranes from human glomeruli and bovine sources. Effect of diabetes and age.

R L Garlick1, H F Bunn, R G Spiro.   

Abstract

The nonenzymatic glycation of glomerular basement membranes (GBMs) from 14 diabetic and 19 nondiabetic human subjects was determined after boronic acid affinity and high-performance cation-exchange chromatography of their NaB[3H]4-reduced ketoamine adducts. The glucitol-lysine (Glc-Lys) and the glucitol-hydroxylysine (Glc-Hyl) content of diabetic GBM was found to be about twofold higher than that of nondiabetic samples (P less than .001). The content of these glycated amino acids did not correlate with age over the range examined (20-91 yr) or with the length of disease in diabetic subjects (2-16 yr). However, analyses of Glc-Lys and Glc-Hyl in calf and adult bovine GBM and lens capsules indicated that the levels of these glycated amino acids were several times greater in basement membranes from older animals. We also observed that guanidine-insoluble collagen of bovine GBM is more extensively glycated (approximately 4-fold) than primarily noncollagenous proteins that are extracted by this reagent. In all of the basement membranes examined, the percentage of glycation of lysine was greater than of hydroxylysine. Characterization of the components released by alkaline hydrolysis indicated that O-glycosylated hydroxylysine residues are nonenzymatically N-glycated to the same extent as those without an enzymatically attached carbohydrate unit. Our study indicates that more than a hundred times as many hydroxylysine residues are enzymatically glycosylated in human and bovine GBM as those containing the nonenzymatically formed ketoamine adduct.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3134265     DOI: 10.2337/diab.37.8.1144

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

Review 1.  [The effect of Maillard reaction products on enzyme reactions].

Authors:  D Schumacher; L W Kroh
Journal:  Z Ernahrungswiss       Date:  1996-09

2.  Practicing biochemistry without a license.

Authors:  H Franklin Bunn
Journal:  J Biol Chem       Date:  2013-01-08       Impact factor: 5.157

3.  Immunogold studies of monomeric elements from the globular domain (NC1) of type IV collagen in renal basement membranes during experimental diabetes in the rat.

Authors:  M Desjardins; F Gros; J Wieslander; M C Gubler; M Bendayan
Journal:  Diabetologia       Date:  1990-11       Impact factor: 10.122

4.  Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate.

Authors:  J van den Born; A A van Kraats; M A Bakker; K J Assmann; L P van den Heuvel; J H Veerkamp; J H Berden
Journal:  Diabetologia       Date:  1995-02       Impact factor: 10.122

5.  Chemistry of collagen cross-links: glucose-mediated covalent cross-linking of type-IV collagen in lens capsules.

Authors:  A J Bailey; T J Sims; N C Avery; C A Miles
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

6.  Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis.

Authors:  Timothy J Lyons; Alicia J Jenkins
Journal:  Diabetes Rev (Alex)       Date:  1997

Review 7.  [The significance of the Maillard reaction in human physiology].

Authors:  E Schleicher
Journal:  Z Ernahrungswiss       Date:  1991-02

8.  Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus.

Authors:  T J Lyons; K E Bailie; D G Dyer; J A Dunn; J W Baynes
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

Review 9.  The lens capsule.

Authors:  Brian P Danysh; Melinda K Duncan
Journal:  Exp Eye Res       Date:  2008-08-16       Impact factor: 3.467

Review 10.  The role of glycation in aging and diabetes mellitus.

Authors:  M A van Boekel
Journal:  Mol Biol Rep       Date:  1991-05       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.